Company news
Puretech Health Plc (LSE:PRTC) news
Puretech Health Plc news releases on 6ix. Latest, Jan 18, 2021: Vor Files IPO Registration Statement on Nasdaq
Press releases — page 6
Vor Files IPO Registration Statement on Nasdaq
January 18, 2021
Vor Announces FDA Acceptance of IND Application
January 14, 2021
Vedanta Receives $25M Investment from Pfizer Inc
January 12, 2021
PRTC Appoints Biotech Analyst & Senior Exec as CFO
January 5, 2021
PureTech to Present at JPM and Other Conferences
December 21, 2020
PRTC Starts LYT-200 Clinical Trial in Solid Tumors
December 11, 2020
LYT-100 Advances to Phase 2a Study in Lymphedema
December 10, 2020
Follica Female Hair Loss Academic Study Published
December 9, 2020
PureTech Initiates Ph 2 of LYT-100 in Long COVID
December 3, 2020
PureTech to Host Virtual R&D Day for Investors
November 30, 2020
Second Price Monitoring Extn
November 27, 2020
Vedanta Appoints Karuna CFO Troy Ignelzi to BOD
November 24, 2020
PRTC LYT-100 Shows PK & Tolerability Ph1 POC
November 18, 2020
PureTech to Present at Three Investor Conferences
November 16, 2020
Guidance for Exchanging Ordinary Shares into ADSs
November 13, 2020
Sonde Respiratory Portal Available to Developers
November 12, 2020
Vor Licenses Clinical-Stage CD33 CAR-T Therapy
November 11, 2020
PureTech Presents at Credit Suisse Conference
November 5, 2020
Gelesis Presents New Data at ObesityWeek
November 3, 2020
PureTech Files Publicly for Nasdaq Listing
October 28, 2020
Akili Presents New Data on EndeavorRx at AACAP
October 21, 2020
Vor Appoints Biotech Leader Matt Patterson to BOD
October 20, 2020
New Vedanta VE202 Data Presented at UEG Week
October 12, 2020
Akili Adds Award-Winning Marketing Leader as CMO
October 7, 2020
Alivio Awarded $3.3M from DoD to Advance ALV-304
October 5, 2020
PureTech Appoints Biocon Founder Kiran Shaw to BOD
October 1, 2020
BARDA Awards Vedanta Up to $76.9M to Advance VE303
September 30, 2020
Alivio Adds Dr Harry Leider to Board of Directors
September 29, 2020
PureTech Nasdaq Listing Progresses
September 23, 2020
Vedanta Appoints Drug Development Leader as CMO
September 16, 2020
Gelesis Presents Plenity Efficacy and Safety Data
September 4, 2020
Vor Appoints John King as Chief Commercial Officer
August 26, 2020
Sonde Makes Acquisition in Vocal Biomarker Space
August 25, 2020
PureTech to Present at Wedbush PacGrow Conference
August 5, 2020
Vor Appoints Life Science Leader to BOD
July 30, 2020
Vor Appoints Biotech Finance Leader to BOD
July 16, 2020
Vor Names Oncology Drug Development Expert as CMO
July 14, 2020
Sonde Launches Voice Health Screening for COVID-19
July 8, 2020
PureTech's Vor Raises $110M Series B Financing
July 7, 2020
Karuna Positive FDA End of Phase 2 Meeting
June 23, 2020
PRTC Presents New Immuno-oncology Data at AACR
June 22, 2020
Gelesis China Deal $35M and up to $388M milestones
June 18, 2020
Akili Granted FDA Clearance for ADHD Treatment
June 16, 2020
Positive Data from Vedanta IBD Clinical Studies
June 9, 2020
Positive FDA Feedback on Follica
June 4, 2020
Gelesis Approved to Market Plenity in Europe
June 2, 2020
PRTC Targets COVID-19 Post-Recovery Complications
May 28, 2020
PRTC to Present at Jefferies Virtual Conference
May 27, 2020
Vor Appoints CFO Nathan Jorgensen
May 26, 2020
PDMR Notification - Transfer From Trust
May 20, 2020